University Hospital San Raffaele Milan IRCCS

University Hospital San Raffaele Milan IRCCS is a world-renowned, unique research center and an advanced hospital. Since 1969, under one roof, in collaboration with Vita-Salute San Raffaele University, there has been a synergy of new clinical research, high-quality patient treatment, and postgraduate training in various medical fields. The clinic is the only Italian member of the European University Hospital Alliance, which brings together nine of the best universities and research hospitals at the European level. Since 2001, it has been recognized by the Italian Ministry of Health in molecular medicine. San Raffaele in Milan covers an area of ​​over 290,000 m². 11 buildings surround an open space with a garden, a restaurant, and an underground shopping center. With 100 high-tech laboratories, 1,350 beds, and 50 medical specialties, it treats more than 50,000 patients annually and conducts more than 880 ongoing clinical trials. In addition, the clinic is home to numerous high-tech certified centers, analogs of which are units around the world: the heart valve and research of venous pathologies center, the reference hub for pediatric diabetes, the European center of advanced experience in the diagnosis and treatment of neuroendocrine tumors of the European Society of Neuroendocrine Tumors. San Raffaele University Clinic's basic science is rapidly being solved in clinical practice, and clinical needs drive basic research. The Institute tries to understand various human diseases' mechanisms and identify new treatment strategies. The world's first stem cell gene therapy for patients with severe combined immunodeficiency was developed by the professional staff of San Raffaele Clinic. A team of gynecologists and neurosurgeons from the hospital successfully performed a complete neurosurgical correction of spina bifida in the middle of the uterus using a unique technique never before used in Europe and reducing the risks to mother and child without affecting subsequent pregnancies. Also, a woman was transplanted with ovarian tissue to fight infertility due to a rare disease after the previous removal. Doctors get invaluable experience and the opportunity to try the latest technologies that meet the safety and high level of treatment efficiency. Professionals in their field receive numerous awards: the Bellisario Golden Apple Award 2021, the Robertson Stem Cell Prize, the Fresenius Award for Biomedical Research, and ARVO for the fight against corneal diseases. At Milan University Hospital San Raffaele, patients receive high treatment results in the most challenging cases after numerous previous studies and ineffective treatments. A robust interdisciplinary knowledge base and new medical opportunities provide unique methods and high results. Rare genetic, immunological, neurological, and rheumatological diseases, valvular heart defects, metabolic disorders, hepatitis B, and COVID-19 are the spectra of interest to doctors. Still, knowledge and experience go far beyond these limits and are undoubtedly a great advantage of this medical center.